Author
Warren E. Regelmann
Also Known As
W E REGELMANN, W E Regelmann, W Regelmann, W. Regelmann, W.R. Regelmann, Warren E Regelmann, Warren E. Regelmann, Warren Regelmann, WarrenE Regelmann
74
Publications
4.3K
Citations
31
H-Index
66
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 17 | 24 | 2.2K |
2 | Health Sciences | 3 | 3 | 275 |
3 | Public Health | 2 | 2 | 181 |
4 | Allergy | 2 | 2 | 353 |
5 | Natural Sciences | 1 | 1 | 68 |
Warren E. Regelmann
×
49
Publications
4.2K
Citations
30
H-Index
| Year | Citations | |
|---|---|---|
2007 | 437 | |
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study Jane C. Davies, Steve Cunningham, William T. Harris, The Lancet Respiratory Medicine Single-arm StudyPathologyPulmonary FibrosisMedicineCftr Gating Mutation | 2016 | 339 |
1984 | 272 | |
1990 | 260 | |
2004 | 249 | |
1986 | 248 | |
2013 | 188 | |
1999 | 172 | |
2007 | 146 | |
1999 | 145 |
Page 1
Page 1